These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22646850)

  • 1. Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28γ knockout in HCV pathogenesis: a network-based study.
    Tripathi LP; Kambara H; Moriishi K; Morita E; Abe T; Mori Y; Chen YA; Matsuura Y; Mizuguchi K
    J Proteome Res; 2012 Jul; 11(7):3664-79. PubMed ID: 22646850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein.
    Miyamoto H; Moriishi K; Moriya K; Murata S; Tanaka K; Suzuki T; Miyamura T; Koike K; Matsuura Y
    J Virol; 2007 Feb; 81(4):1727-35. PubMed ID: 17135326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network based analysis of hepatitis C virus core and NS4B protein interactions.
    Tripathi LP; Kataoka C; Taguwa S; Moriishi K; Mori Y; Matsuura Y; Mizuguchi K
    Mol Biosyst; 2010 Dec; 6(12):2539-53. PubMed ID: 20953506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal HCV core protein fragment decreases 20S proteasome activity in the presence of PA28γ.
    Zheng Y; Shimamoto S; Maruno T; Kobayashi Y; Matsuura Y; Kawahara K; Yoshida T; Ohkubo T
    Biochem Biophys Res Commun; 2019 Feb; 509(2):590-595. PubMed ID: 30602418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of PA28gamma in the propagation of hepatitis C virus.
    Moriishi K; Shoji I; Mori Y; Suzuki R; Suzuki T; Kataoka C; Matsuura Y
    Hepatology; 2010 Aug; 52(2):411-20. PubMed ID: 20683941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis.
    Moriishi K; Mochizuki R; Moriya K; Miyamoto H; Mori Y; Abe T; Murata S; Tanaka K; Miyamura T; Suzuki T; Koike K; Matsuura Y
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1661-6. PubMed ID: 17234812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus core protein: its coordinate roles with PA28gamma in metabolic abnormality and carcinogenicity in the liver.
    Mori Y; Moriishi K; Matsuura Y
    Int J Biochem Cell Biol; 2008; 40(8):1437-42. PubMed ID: 18321762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.
    Moriishi K; Okabayashi T; Nakai K; Moriya K; Koike K; Murata S; Chiba T; Tanaka K; Suzuki R; Suzuki T; Miyamura T; Matsuura Y
    J Virol; 2003 Oct; 77(19):10237-49. PubMed ID: 12970408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus core activates proteasomal activator 28γ expression via upregulation of p53 levels to control virus propagation.
    Kwak J; Tiwari I; Jang KL
    J Gen Virol; 2017 Jan; 98(1):56-67. PubMed ID: 27902328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Core protein of hepatitis C virus expressed in transgenic mice is associated with the expression of Fas molecule].
    Tan W; Lang Z; Cong Y; Chen G; Miao J; Zhan M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):205-7. PubMed ID: 15617329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis.
    Aizawa S; Okamoto T; Sugiyama Y; Kouwaki T; Ito A; Suzuki T; Ono C; Fukuhara T; Yamamoto M; Okochi M; Hiraga N; Imamura M; Chayama K; Suzuki R; Shoji I; Moriishi K; Moriya K; Koike K; Matsuura Y
    Nat Commun; 2016 May; 7():11379. PubMed ID: 27142248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.
    Chang S; Dolganiuc A; Szabo G
    J Leukoc Biol; 2007 Sep; 82(3):479-87. PubMed ID: 17595379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
    Tokushige K; Wakita T; Pachuk C; Moradpour D; Weiner DB; Zurawski VR; Wands JR
    Hepatology; 1996 Jul; 24(1):14-20. PubMed ID: 8707253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
    Large MK; Kittlesen DJ; Hahn YS
    J Immunol; 1999 Jan; 162(2):931-8. PubMed ID: 9916717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product.
    Vassilaki N; Mavromara P
    IUBMB Life; 2009 Jul; 61(7):739-52. PubMed ID: 19548320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.
    Mansilla C; Gorraiz M; Martinez M; Casares N; Arribillaga L; Rudilla F; Echeverria I; Riezu-Boj JI; Sarobe P; Borrás-Cuesta F; Prieto J; Lasarte JJ
    J Hepatol; 2009 Sep; 51(3):520-7. PubMed ID: 19596480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.